000 | 01749 a2200481 4500 | ||
---|---|---|---|
005 | 20250517000012.0 | ||
264 | 0 | _c20150812 | |
008 | 201508s 0 0 eng d | ||
022 | _a1879-291X | ||
024 | 7 |
_a10.1016/j.ultrasmedbio.2014.06.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeguerney, Ingrid | |
245 | 0 | 0 |
_aMolecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin. _h[electronic resource] |
260 |
_bUltrasound in medicine & biology _cJan 2015 |
||
300 |
_a197-207 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aContrast Media _xpharmacokinetics |
650 | 0 | 4 | _aEndoglin |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aIntegrin alphaV _xmetabolism |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
650 | 0 | 4 |
_aMelanoma _xdiagnostic imaging |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aMolecular Imaging _xmethods |
650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
650 | 0 | 4 | _aSorafenib |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUltrasonography _xmethods |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xmetabolism |
700 | 1 | _aScoazec, Jean-Yves | |
700 | 1 | _aGadot, Nicolas | |
700 | 1 | _aRobin, Nina | |
700 | 1 | _aPénault-Llorca, Frédérique | |
700 | 1 | _aVictorin, Steeve | |
700 | 1 | _aLassau, Nathalie | |
773 | 0 |
_tUltrasound in medicine & biology _gvol. 41 _gno. 1 _gp. 197-207 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ultrasmedbio.2014.06.014 _zAvailable from publisher's website |
999 |
_c24272294 _d24272294 |